Delta Financial Advisors’s Amedisys AMED Stock Holding History

Delta Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,915	Closed	-$201K	–	111
2022 Q2	$201K	Hold	1,915	–	–	0.1%	115
2022 Q1	$330K	Hold	1,915	–	–	0.14%	107
2021 Q4	$310K	Hold	1,915	–	–	0.13%	108
2021 Q3	$286K	Hold	1,915	–	–	0.13%	105
2021 Q2	$469K	Hold	1,915	–	–	0.21%	96
2021 Q1	$507K	Hold	1,915	–	–	0.24%	93
2020 Q4	$562K	Hold	1,915	–	–	0.28%	88
2020 Q3	$453K	Hold	1,915	–	–	0.25%	92
2020 Q2	$380K	Hold	1,915	–	–	0.22%	91
2020 Q1	$351K	Hold	1,915	–	–	0.24%	87
2019 Q4	$320K	Hold	1,915	–	–	0.13%	103
2019 Q3	$251K	Hold	1,915	–	–	0.1%	111
2019 Q2	$233K	Buy	+1,915	New	+$227K	0.1%	111

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Delta Financial Advisors's AMED Position: Q3 2022 in Review

Delta Financial Advisors sold out of Amedisys (AMED) in Q3 2022, closing a stake of 1,915 shares — an estimated $201K sold.

Delta Financial Advisors first reported a position in AMED in Q2 2019 and held it in 13 quarters. The position peaked at $562K in Q4 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

Delta Financial Advisors reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
Delta Financial Advisors sold 1,915 Amedisys shares in Q3 2022, an estimated $201K.
Delta Financial Advisors first reported a position in Amedisys in Q2 2019 and held it in 13 quarters.
Delta Financial Advisors's Amedisys position peaked at $562K in Q4 2020.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Delta Financial Advisors's 13F filing for Q3 2022, filed 27 Oct 2022.